ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,296.20
-0.32%
S&P ASX All Technology
4,030.80
-1.66%
Brent Oil
73.935
0.00%
US Dollar vs AUD
1.57356
0.00%
Bitcoin
96,422.78
0.29%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Praxis Precision Medicines Inc (PRAX) Share Price

Praxis Precision Medicines Inc

Praxis Precision Medicines Inc (PRAX)

NASDAQ
74.49
-5.05
(-6.35%)
Closed 22 February 8:00AM
Delayed by 15 minutes
74.50
0.01
(0.01%)
After Hours: 11:59AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
74.49
Bid
50.75
Offer
76.00
Volume
496,981
74.30 Day's Range 81.64
33.01 52 Week Range 91.83
Market Cap
1.388B
Previous Close
79.54
Open
80.56
Last Trade
2
@
75.99
Last Trade Time
Financial Volume
US$ 38,429,491
VWAP
77.3259
Average Volume (3m)
360,318
Shares Outstanding
18,637,777
Dividend Yield
-
PE Ratio
-11.23
Earnings Per Share (EPS)
-6.61
Revenue
2.45M
Net Profit
-123.28M

About Praxis Precision Medicines Inc

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, fo... Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.praxismedicines.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Praxis Precision Medicines Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRAX. The last closing price for Praxis Precision Medicines was US$79.54. Over the last year, Praxis Precision Medicines shares have traded in a share price range of US$ 33.01 to US$ 91.83.

Praxis Precision Medicines currently has 18,637,777 shares in issue. The market capitalisation of Praxis Precision Medicines is US$1.48 billion. Praxis Precision Medicines has a price to earnings ratio (PE ratio) of -11.23.

Ask ADVFN Intelligence (AI)

Praxis Precision Medicines (PRAX) Options Flow Summary

PRAX Options Flow

Overall Flow

Bearish

Net Premium

-282k

Calls / Puts

25.00%

Buys / Sells

125.00%

OTM / ITM

233.33%

Sweeps Ratio

0.00%

PRAX Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 February 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 February 2025
PRAX (-6.35%)

Form 8-K - Current report
Edgar (US Regulatory)
30 January 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 January 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 January 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 January 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
15 January 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 January 2025
PRAX (-6.35%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
09 January 2025
PRAX (-6.35%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-12.72-14.585483316187.2191.8374.349413283.15548171CS
4-3.16-4.0695428203577.6591.8370.838242182.4519635CS
12-4.92-6.1956932376379.4191.8360.0736031876.7362612CS
2622.3842.947610823352.1191.8348.2232592371.84939169CS
5234.3285.436893203940.1791.8333.0130033661.54090721CS
156-116.01-60.8976377953190.521011.8579115336.96807549CS
260-333.66-81.7493568541408.15914.257511.8563004083.88292342CS

PRAX - Frequently Asked Questions (FAQ)

What is the current Praxis Precision Medicines share price?
The current share price of Praxis Precision Medicines is US$ 74.49
How many Praxis Precision Medicines shares are in issue?
Praxis Precision Medicines has 18,637,777 shares in issue
What is the market cap of Praxis Precision Medicines?
The market capitalisation of Praxis Precision Medicines is USD 1.48B
What is the 1 year trading range for Praxis Precision Medicines share price?
Praxis Precision Medicines has traded in the range of US$ 33.01 to US$ 91.83 during the past year
What is the PE ratio of Praxis Precision Medicines?
The price to earnings ratio of Praxis Precision Medicines is -11.23
What is the cash to sales ratio of Praxis Precision Medicines?
The cash to sales ratio of Praxis Precision Medicines is 565.88
What is the reporting currency for Praxis Precision Medicines?
Praxis Precision Medicines reports financial results in USD
What is the latest annual turnover for Praxis Precision Medicines?
The latest annual turnover of Praxis Precision Medicines is USD 2.45M
What is the latest annual profit for Praxis Precision Medicines?
The latest annual profit of Praxis Precision Medicines is USD -123.28M
What is the registered address of Praxis Precision Medicines?
The registered address for Praxis Precision Medicines is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Praxis Precision Medicines website address?
The website address for Praxis Precision Medicines is www.praxismedicines.com
Which industry sector does Praxis Precision Medicines operate in?
Praxis Precision Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
BOXLBoxlight Corporation
US$ 3.1099
(51.70%)
1.84M
GDEVGDEV Inc
US$ 20.90
(46.56%)
264.44k
IVVDInvivyd Inc
US$ 1.7501
(44.64%)
37.75M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
DOYUDouYu International Holdings Ltd
US$ 7.19
(-55.31%)
1.28M
MNDRMobile health Network Solutions
US$ 0.5048
(-46.29%)
18.61M
BLUEbluebird bio Inc
US$ 4.09
(-41.90%)
5.44M
FLDFold Holdings Inc
US$ 6.95
(-37.39%)
488.54k
GCLGCL Global Holdings Ltd
US$ 3.83
(-31.48%)
635.26k
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
ADTXAditxt Inc
US$ 0.0922
(-22.39%)
278.25M
NVDANVIDIA Corporation
US$ 134.43
(-4.05%)
228.14M
HOLOMicroCloud Hologram Inc
US$ 1.565
(31.51%)
190.81M

PRAX Discussion

View Posts
Monksdream Monksdream 5 months ago
PRAX near a 52/week high

👍️0
Monksdream Monksdream 1 year ago
PRAX under $2
👍️0
richme richme 2 years ago
Do you still have your 10K shares?

Hope this one goes up to new heights in $5+ in the next month or so.
👍️0
makinezmoney makinezmoney 2 years ago
$PRAX: Added 10k here now at 1.22


Technically........ bullish ...... should get to $1.80 min



GO $PRAX
👍️0
ctb ctb 2 years ago
Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study
Vandana Singh
Fri, March 3, 2023 at 8:05 AM PST

https://finance.yahoo.com/news/despite-trial-failure-praxis-still-160535252.html
👍️0
IPO$ IPO$ 2 years ago
News today.
👍️0
IPO$ IPO$ 2 years ago
Not looking good now.
👍️0
IPO$ IPO$ 2 years ago
Getting killed this am.
👍️0
IPO$ IPO$ 2 years ago
FDA phase 2 approval due in next week or so.
👍️0
IPO$ IPO$ 2 years ago
ATM offering on S-3 didn’t hurt 2022 as avg price was $3.90 per share but not sure on 2023.
👍️0
IPO$ IPO$ 2 years ago
Book value at 12/31/22 is $76M. Not bad. They say they have enough cash entering 2023.
👍️0
IPO$ IPO$ 2 years ago
$61M cash at 12/31/22 with 49M shares O/S for about $1.30 in cash per share.
👍️0
IPO$ IPO$ 2 years ago
I wonder how much cash they have now?
👍️0
ElCollector ElCollector 3 years ago
$PRAX has $5 a share cash and easily going from $2 to $3 for my collection....patiently waiting
👍️0
rtrstock rtrstock 4 years ago
Looking for a gain.
👍️0

Your Recent History

NASDAQ
PRAX
Praxis Precision Medicines
BIT
EUDV
Ssga Spdr S&p Euro Divid...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads